Purchase Order 36C26023P0034
Award Date
10/1/22
Potential Completion Date
9/30/23
Potential Value
$313K
Federal Agency
Veterans Integrated Service Network 20
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The $75,208.70 contract is for the provision of pharmaceutical products, with a focus on specialized medications for rare, chronic, or complex medical conditions, such as Jynarque (tolvaptan) for autosomal dominant polycystic kidney disease. The contract does not have a...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain, for the supply of Jynarque (tolvaptan) 45/105mg tablets. The contract has a ceiling value of $12,580.72 and a period of performance through October 18, 2024. Walgreens Specialty Pharmacy is the prime contractor on this contract, with no subcontractors or set-aside...
This federal contract award, with an ID of 36C24225P0094, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, doing business as Walgreens, as the prime contractor. The $12,580.72 firm fixed price purchase order is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets to VA facilities. Walgreens Specialty Pharmacy, a for-profit organization, has been providing specialized pharmaceutical...
This is a firm fixed price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain. The $12,580.72 contract is for the supply of Jynarque 45mg/15mg tablets, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease. The contract has a performance period from June 5, 2024 to September 5, 2024 and was not set aside for...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the emergency procurement of the medication Jynarque (tolvaptan) to support the VA's healthcare services for veterans. The contract has a period of performance through July 7, 2025 and does not have a set-aside designation,...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $83,000.32, is for the supply of the pharmaceutical drug JYNARQUE (tolvaptan) to treat autosomal dominant polycystic kidney disease. The contract does not have a set-aside designation and has an ultimate completion date of September 30, 2021. Walgreens...
This is a $13,242.99 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) to the VA's Veterans Integrated Service Network 2 (VISN 2). The award has no set-aside designation, indicating it is open to all qualified vendors. The performance period runs from the award date of April 30, 2025 through the...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a firm fixed price purchase order contract to Walgreens Specialty Pharmacy, LLC to provide the branded medication Jynarque 45mg/15mg to the Northport VA Medical Center. The contract has a potential value of $12,580.72 and a period of performance through May 7, 2024. No set-aside designation was used for this contract. As the prime contractor, Walgreens Specialty Pharmacy will rapidly deliver this specialty...
The Department of Veterans Affairs Veterans Health Administration awarded Walgreens Specialty Pharmacy, LLC a $12,224.60 firm fixed price purchase order under the Veterans Integrated Service Network 2 vehicle to deliver JYNARQUE 45MG/15MG tablets from July 6, 2023 through October 6, 2023. Walgreens Specialty Pharmacy, LLC will perform from its location in Pittsburgh, Pennsylvania to supply the requested pharmaceutical products in support of VHA's mission to provide healthcare services to...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the emergency purchase of the medication Jynarque 45mg/15mg for the Northport VA Medical Center. The contract has no set-aside designation and is awarded to Walgreens Specialty Pharmacy as the prime contractor, with no subcontractors mentioned. The award is part of...